R&D News | pharmaphorum

News

The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area.

News

Another clinical trial setback disappoints the ALS patient community, this time involving Denali's eIF2B agonist DNL343.

News

US biotech NeOnc Technologies has applied to list on the Nasdaq as it advances a portfolio of drugs to treat diseases affecting the CNS.

News

The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.

News

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.

News

Regeneron has bought Oxular, a UK specialist in retinal diseases, in a move that bolsters its already strong position in ophthalmology therapies.